WHO Approves Bavarian Nordic’s Mpox Vaccine for Adolescents
The World Health Organization (WHO) has approved Bavarian Nordic’s mpox vaccine, Jynneos, for adolescents aged 12 to 17. This age group is considered especially vulnerable […]
The World Health Organization (WHO) has approved Bavarian Nordic’s mpox vaccine, Jynneos, for adolescents aged 12 to 17. This age group is considered especially vulnerable […]
The World Health Organization (WHO) has added the MVA-BN vaccine to its prequalification list as the first approved vaccine for mpox. This prequalification aims to […]
Pharmacists Driving Better Outcomes in MS Care Multiple sclerosis (MS) is a chronic, unpredictable disease that requires a coordinated approach to care. While neurologists lead […]
Sibeprenlimab-szsi: Redefining IgA Nephropathy Care Primary IgA nephropathy (IgAN) is one of the most common causes of chronic kidney disease worldwide. Despite optimized supportive care—such […]
Delays in Pricing Notifications Threaten Patient Care Pakistan is grappling with a severe shortage of critical medicines, sparking concern among doctors, patients, and the pharmaceutical […]
Leadership Shake-Up at Punjab Dental Hospital The Punjab government has issued a formal notification suspending the Medical Superintendent (MS) of Punjab Dental Hospital in Lahore. […]
Mpox Cases Trigger Provincial Health Alert The Health Department of Khyber Pakhtunkhwa has officially confirmed 26 cases of mpox (monkeypox), prompting a province-wide alert to […]
Reproductive Health Education Gains Parliamentary Approval Pakistan has taken a significant step toward improving adolescent health by approving a bill that introduces reproductive health education […]